185 related articles for article (PubMed ID: 8583243)
1. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
[TBL] [Abstract][Full Text] [Related]
2. Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract.
Mhawech P; Berczy M; Assaly M; Herrmann F; Bouzourene H; Allal AS; Dulguerov P; Schwaller J
Am J Clin Pathol; 2004 Jul; 122(1):100-5. PubMed ID: 15272537
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
[TBL] [Abstract][Full Text] [Related]
4. Odorant receptor genes are expressed in olfactory neuroblastoma.
Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
[TBL] [Abstract][Full Text] [Related]
5. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
[TBL] [Abstract][Full Text] [Related]
6. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.
Czapiewski P; Gorczyński A; Haybaeck J; Okoń K; Reszeć J; Skrzypczak W; Dzierżanowski J; Kunc M; Karczewska J; Biernat W
Pol J Pathol; 2016 Jun; 67(2):130-5. PubMed ID: 27543867
[TBL] [Abstract][Full Text] [Related]
8. Expressions of NeuroD and GAP43 as diagnostic markers for olfactory neuroblastoma.
Furukawa T; Tatehara S; Teshima M; Shinomiya H; Inokuchi G; Komatsu M; Hara S; Zen Y; Nibu KI
Auris Nasus Larynx; 2023 Jun; 50(3):358-364. PubMed ID: 35999123
[TBL] [Abstract][Full Text] [Related]
9. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.
Mao L; Xia YP; Zhou YN; Dai RL; Yang X; Wang YJ; Duan SJ; Qiao X; Mei YW; Hu B
Oncology; 2009; 77(3-4):231-43. PubMed ID: 19738389
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
12. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract][Full Text] [Related]
13. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors.
Taggart MW; Hanna EY; Gidley P; Weber RS; Bell D
Ann Diagn Pathol; 2015 Jun; 19(3):154-6. PubMed ID: 25892663
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.
Chen H; Biel MA; Borges MW; Thiagalingam A; Nelkin BD; Baylin SB; Ball DW
Cell Growth Differ; 1997 Jun; 8(6):677-86. PubMed ID: 9186001
[TBL] [Abstract][Full Text] [Related]
15. [Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma].
Zeng M; Cui Y; Wu C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):690-2. PubMed ID: 20942237
[TBL] [Abstract][Full Text] [Related]
16. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
[TBL] [Abstract][Full Text] [Related]
18. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
19. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.
Chen H; Thiagalingam A; Chopra H; Borges MW; Feder JN; Nelkin BD; Baylin SB; Ball DW
Proc Natl Acad Sci U S A; 1997 May; 94(10):5355-60. PubMed ID: 9144241
[TBL] [Abstract][Full Text] [Related]
20. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]